EUVIMEDEUVIMED entdecken
Crossref

Hemoglobin is an independent predictor of improvement exercise tolerance in male patients with non-ischemic cardiomyopathy

Akiko Tanihata, Atsushi Shibata, Toshitake Yoshida, Ryoko Kitada, Yasuhiro Izumiya, Daiju Fukuda

Heart and Vessels · 2024

DOI: 10.1007/s00380-024-02358-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Heart and Vessels, 2024. Verfasst von Akiko Tanihata und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine, 1-4-3, Asahi-machi, Abeno-ku, Osaka, 545-8585, Japa…. Hauptthemen laut MEDLINE: Heart Failure, Cardiomyopathies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Exercise intolerance is a symptom of chronic heart failure (CHF). The magnitude of exercise tolerance, as measured by peak oxygen uptake (peak VO2), is strongly associated with prognosis in patients with CHF. We aimed to evaluate the factors associated with improved exercise tolerance in patients with HF. In this prospective study, we recruited patients who were diagnosed with non-ischemic cardiomyopathy between September 2017 and September 2021. All patients underwent cardiopulmonary exercise testing at discharge and 6 months after enrollment. The patients were stratified according to whether peak VO2 was increased or not at 6 months. One hundred patients with a reduced left-ventricular ejection fraction (LVEF < 50%) were enrolled. Improvement of peak VO2 was observed in 74 patients. In male patients, hemoglobin level was higher in the increased peak VO2 group than in the non-increased group (15.0 ± 1.9 g/dL vs. 13.1 ± 2.1 g/dL; p < 0.01). Baseline hemoglobin level was positively correlated with the percentage change in peak VO2 (Spearman's r = 0.248, p = 0.040). Kaplan-Meier analysis demonstrated that adverse cardiac events were significantly less frequent in the increased peak VO2 group than in the non-increased group (log-rank test, p = 0.032). Multivariate logistic regression analysis identified hemoglobin level as an independent predictor of improved peak VO2 [odds ratio (OR) 1.60; 95% confidence interval (CI) 1.05-2.44; p = 0.027]. Baseline hemoglobin level is an independent predictor of improved peak VO2 in male patients with non-ischemic cardiomyopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureCardiomyopathiesHumansMaleStroke VolumeVentricular Function, LeftExercise ToleranceProspective StudiesExercise TestHemoglobinsOxygen Consumption

Stichwörter der Autor:innen

AnemiaExercise toleranceHeart failureNon-ischemic cardiomyopathy

Substanzen

Hemoglobins

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine, 1-4-3, Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
  • Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine, 1-4-3, Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan. q21008c@omu.ac.jp.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Tanihata, A., Shibata, A., Yoshida, T., Kitada, R., Izumiya, Y., & Fukuda, D. (2024). Hemoglobin is an independent predictor of improvement exercise tolerance in male patients with non-ischemic cardiomyopathy. Heart and Vessels. https://doi.org/10.1007/s00380-024-02358-w

Vancouver

Tanihata A, Shibata A, Yoshida T, Kitada R, Izumiya Y, Fukuda D. Hemoglobin is an independent predictor of improvement exercise tolerance in male patients with non-ischemic cardiomyopathy. Heart and Vessels. 2024. doi:10.1007/s00380-024-02358-w

BibTeX
@article{Tanihata2024,
  author = {Tanihata, Akiko and Shibata, Atsushi and Yoshida, Toshitake and Kitada, Ryoko and Izumiya, Yasuhiro and Fukuda, Daiju},
  title = {Hemoglobin is an independent predictor of improvement exercise tolerance in male patients with non-ischemic cardiomyopathy},
  journal = {Heart and Vessels},
  year = {2024},
  doi = {10.1007/s00380-024-02358-w}
}
Kostenlos starten →